Sarah Wilson

Dr. Sarah Wilson is a Canadian public health physician and epidemiologist based in Toronto, Ontario.

Wilson received a Doctor of Medicine from the University of Toronto, and a Master of Science in Public Health from the London School of Hygiene and Tropical Medicine. She is a certificant of the Canadian College of Family Medicine (CCFP).

Wilson is a Fellow of the Royal College of Physicians and Surgeons of Canada in Public Health and Preventative Medicine.

Wilson is a graduate of the Canadian Field Epidemiology Program. The CFEP “mobilizes field epidemiologists anywhere they are needed within Canada or around the world, supporting public health organizations as they respond to urgent public health events.”¹⁾

CFEP is also a partner in the Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET) and occasionally responds to requests from the World Health Organization's Global Outbreak Alert and Response Network (GOARN). As a result of these connections, Field Epidemiologists may have the opportunity to present their work at international conferences and support investigations outside Canada.

Wilson is a medical epidemiologist and researcher in health protection at Public Health Ontario, where she works closely with the Immunization and Vaccine-Preventable Diseases team within the Communicable Diseases and Emergency Preparedness Response Department.²⁾ She began at PHO in June 2012. She is a member of the Provincial Infectious Diseases Advisory Committee on Immunization (PIDAC-I).

In this role, she provides support to the surveillance of vaccine-preventable diseases, immunization coverage, vaccine safety, outbreak management, and participates in applied research. This includes providing scientific and technical advice to the Ontario Ministry of Health in regards to the implementation and monitoring of immunization programs.

She represents PHO as a member of Immunization Canada as of November 2019.

Wilson is a clinical associate at Women's College Hospital.³⁾ WCH is funded through their foundation by Allergan, Amgen, Bayer, BD, and Canadian Cancer Society.⁴⁾

Wilson is an Assistant Professor at the Dalla Lana School of Public Health at the University of Toronto.⁵⁾ She is a member of U of T's Centre for Vaccine Preventable Diseases as a member of its Education committee since April 2017.

Wilson is a researcher at the Canadian Immunization Research Network (CIRN), participating as a co-investigator in their Reference Laboratory and Provincial Collaborative networks.^{6) 7)} CIRN is funded by GlaxoSmithKline, Novartis, Pfizer, Sanofi, and VBI Vaccines.

Wilson is an Adjunct Scientist at the Institute for Clinical Evaluative Studies (ICES).⁸⁾

Wilson is a member of the National Advisory Committee on Immunization (NACI), where she was responsible for initially approving COVID-19 vaccines in Canada.⁹⁾

She is also a member of the Vaccine Safety Working Group under the Vaccine Surveillance Reference Group (VSRG) of the COVID-19 Immunity Task Force.¹⁰⁾

Wilson's research interests include applied vaccine program evaluation and immunization coverage assessment using a range of data sources including both routine surveillance and administrative data.

Wilson has received research funding from the Public Health Agency of Canada, the COVID-19 Immunity Task Force, Ontario Health Data Platform, and the Canadian Institutes of Health Research (CIHR) through the Canadian Immunization Research Network (CIRN).^{11) 12)}